<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HB3A0C44C661B4D88848A050D08B63F19" public-private="public" key="H" bill-type="olc">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 5599 IH: Animal Health and Innovation Act of 2018</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-04-24</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
<congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session>
<legis-num display="yes">H. R. 5599</legis-num>
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
<action display="yes">
<action-date date="20180424">April 24, 2018</action-date>
<action-desc><sponsor name-id="H001067">Mr. Hudson</sponsor> (for himself, <cosponsor name-id="S001180">Mr. Schrader</cosponsor>, <cosponsor name-id="B001275">Mr. Bucshon</cosponsor>, <cosponsor name-id="B001251">Mr. Butterfield</cosponsor>, and <cosponsor name-id="M001190">Mr. Mullin</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc>
</action>
<legis-type>A BILL</legis-type>
<official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to expand the conditional approval pathway for more animal drugs, and for other purposes.</official-title>
</form>
<legis-body id="HE7CE717C17034D7E8386D9891153E425" style="OLC"> 
<section id="H1BDA1B6A223748DEB9E7B58C808750CA" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Animal Health and Innovation Act of 2018</short-title></quote>. </text></section> <section id="HC2E1305EEEC242D0A4C43EFB3D7EFBB8"><enum>2.</enum><header>Conditional approval of new animal drugs</header><text display-inline="no-display-inline">Section 571 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360ccc">21 U.S.C. 360ccc</external-xref>) is amended—</text> 
<paragraph id="H8872957879624E8F85F5DE8E856B04C3"><enum>(1)</enum><text>in the section heading, by striking <quote><header-in-text level="section" style="OLC">species</header-in-text></quote> and inserting <quote><header-in-text level="section" style="OLC">species and certain new animal drugs</header-in-text></quote>;</text></paragraph> <paragraph id="HCA8529E8B8DF47A688B2CCB7074088DB"><enum>(2)</enum><text>in subsection (a)—</text> 
<subparagraph id="H700C0A68769844DFA93D99D9B186D566"><enum>(A)</enum><text>by amending paragraph (1) to read as follows: </text> <quoted-block style="OLC" id="H92E2A9BEC74145F4943A7F21A8D76516" display-inline="no-display-inline"> <paragraph id="H2CF1A77E042A406A86216EC001816E8E"><enum>(1)</enum> <subparagraph id="HE1257D940DD348A7AD10D132D11D171B" display-inline="yes-display-inline"><enum>(A)</enum><text display-inline="yes-display-inline">Except as provided in paragraph (3), any person may file with the Secretary an application for conditional approval of—</text> 
<clause id="HF06886F9B09C45C7A85B5AE023427D9A" indent="up1"><enum>(i)</enum><text>a new animal drug intended for a minor use or a minor species; or</text></clause> <clause id="H98E7E2F5A1EA498ABA57C9DD7D13C5C3" indent="up1"><enum>(ii)</enum><text>a new animal drug not intended for a minor use or minor species—</text> 
<subclause id="HFFA1D2ACD5654356B16ECC5C2ECD87EB"><enum>(I)</enum><text display-inline="yes-display-inline">that is intended to treat a serious or life-threatening disease or condition or addresses an unmet animal or human health need; and</text></subclause> <subclause id="HE7BBFEE633214D94938ADFE80561220E"><enum>(II)</enum><text display-inline="yes-display-inline">for which the Secretary determines that a demonstration of effectiveness would require a complex or particularly difficult study or studies.</text></subclause></clause></subparagraph> 
<subparagraph id="H8D6201D39770492E8DDD908CB32D8B2D" indent="up1"><enum>(B)</enum><text>The Secretary shall, not later than September 30, 2019, issue guidance or regulations further clarifying the criteria specified in subparagraph (A)(ii). </text></subparagraph> <subparagraph id="H2A160BBBEF5C40FD8A89747F793840F0" indent="up1"><enum>(C)</enum><text>An application under this paragraph shall comply in all respects with the provisions of section 512 except for subsections (a)(4), (b)(2), (c)(1), (c)(2), (c)(3), (d)(1), (e), (h), and (n) of such section unless otherwise stated in this section, and any additional provisions of this section. </text></subparagraph> 
<subparagraph id="H943BB969F6F544C5A903E17519FFB684" indent="up1"><enum>(D)</enum><text>New animal drugs conditionally approved under this section are subject to application of the same safety standards that would be applied to new animal drugs approved under section 512(d) (including, for antimicrobial new animal drugs, with respect to antimicrobial resistance).</text></subparagraph></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph> <subparagraph id="H820DF85B8077493FA0D17841E5CB30D2"><enum>(B)</enum><text>in paragraph (3)—</text> 
<clause id="H4F94697E6C1A40A98E1426482D25F756"><enum>(i)</enum><text>in subparagraph (A), by striking the period at the end and inserting <quote>or a new animal drug that is an antibiotic drug;</quote>; and</text></clause> <clause id="H43CD663F60764FF6B3DC7EF15A9382FB"><enum>(ii)</enum><text>in subparagraph (B), by striking <quote>; or</quote> and inserting <quote>; or</quote>; and</text></clause></subparagraph></paragraph> 
<paragraph id="H192F450062304616ABC83BBFF92BDD45"><enum>(3)</enum><text>in subsection (f)—</text> <subparagraph id="H747994862312445DBA6D9C2108AC7F11"><enum>(A)</enum><text>in paragraph (1), in the matter preceding subparagraph (A), by inserting <quote>for the conditionally approved use</quote> after <quote>shall</quote>; and</text></subparagraph> 
<subparagraph id="H8D32F82665594FFC800A34239EB42520"><enum>(B)</enum><text>in paragraph (2)—</text> <clause id="HD0CCA686D19642A3AE2C305B3193240E"><enum>(i)</enum><text>by striking <quote>An intended use</quote> and inserting <quote>The Secretary shall, through regulation or guidance, determine under what conditions an intended use</quote>; and</text></clause> 
<clause id="H0B583AA711384196800B09F972AAE6B3"><enum>(ii)</enum><text display-inline="yes-display-inline">by striking <quote>shall not</quote> and inserting <quote>may</quote>. </text></clause></subparagraph></paragraph></section> </legis-body> </bill> 

